These have mostly focused on re-introduction of VHL into VHL-defective ccRCC cell lines (15), or VHL inactivation in previously immortalized or transformed renal cells (16) and do not necessarily capture renal cell–specific effects or progression over time. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.